Eikon Therapeutics, Inc. (EIKN)
Data as of , from SEC Form 4 filings.
See up to 3 months of EIKN. The 7-day demo opens the 1M and 3M ranges and puts EIKN on your watchlist.
Start 7-day demoLatest EIKN insider trades
About Eikon Therapeutics, Inc. (EIKN)
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.
- MILLBRAE, CA
- 384
- 2026
- Nasdaq
EIKN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 89,200 | $1.03M |
EIKN insider transactions (Form 4)
8814 Form 4 filings on record, the earliest from Feb 6, 2026, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Column Group IV GP, LP - 10% Owner | Open-market purchase | Common Stock | 89,200 | $11.56 footnote F1 | $1.03M | |
| ||||||
| Michael A. Klobuchar - Officer | Grant or award | Stock Option (Right to Buy) | 87,157 | $0.00 | - | |
| Robert Luther Huffines | Grant or award | Stock Option (Right to Buy) | 25,873 | $0.00 | - | |
 Kenneth C. Frazier | Grant or award | Stock Option (Right to Buy) | 25,873 | $0.00 | - | |
| Roger M. Perlmutter - Officer | Grant or award | Stock Option (Right to Buy) | 268,176 | $0.00 | - | |
| Benjamin Bruno Thorner - Officer | Grant or award | Stock Option (Right to Buy) | 67,044 | $0.00 | - | |
| Roy D. Baynes - Officer | Grant or award | Stock Option (Right to Buy) | 134,088 | $0.00 | - | |
 Alfred Lloyd Bowie Jr. - Officer | Grant or award | Stock Option (Right to Buy) | 67,044 | $0.00 | - | |
| Roger M. Perlmutter - Officer | Other | Common Stock | 284,857 | - footnote F1,F2 | - | |
| Roger M. Perlmutter - Officer | Other | Series A-1 Preferred Stock | 1,268,891 | - footnote F1 | - | |
| Roger M. Perlmutter - Officer | Other | Series D Preferred Stock | 855,512 | - footnote F2 | - | |
| ||||||
| Column Group IV GP, LP | Other | Common Stock | 1,296,629 | - footnote F1 | - | |
| Column Group IV GP, LP | Other | Common Stock | 1,403,568 | - footnote F1 | - | |
| Column Group IV GP, LP | Other | Common Stock | 110,928 | - footnote F1 | - | |
| Column Group IV GP, LP | Other | Common Stock | 44,249 | - footnote F1 | - | |
| Column Group IV GP, LP | Other | Common Stock | 47,898 | - footnote F1 | - | |
| Column Group IV GP, LP | Other | Common Stock | 3,785 | - footnote F1 | - | |
| Column Group IV GP, LP | Other | Common Stock | 688,283 | - footnote F1 | - | |
| Column Group IV GP, LP | Open-market purchase | Common Stock | 1,437,323 | $18.00 | $25.87M | |
| Column Group IV GP, LP | Open-market purchase | Common Stock | 49,556 | $18.00 | $892K | |
| Column Group IV GP, LP | Open-market purchase | Common Stock | 630,881 | $18.00 | $11.36M | |
| Column Group IV GP, LP | Other | Series A Preferred Stock | 9,670,000 | - footnote F1 | - | |
| Column Group IV GP, LP | Other | Series A Preferred Stock | 330,000 | - footnote F1 | - | |
| Column Group IV GP, LP | Other | Series A-1 Preferred Stock | 10,467,526 | - footnote F1 | - | |
| Column Group IV GP, LP | Other | Series A-1 Preferred Stock | 357,216 | - footnote F1 | - | |
| Column Group IV GP, LP | Other | Series C-1 Preferred Stock | 827,278 | - footnote F1 | - | |
| Column Group IV GP, LP | Other | Series C-1 Preferred Stock | 28,229 | - footnote F1 | - | |
| Column Group IV GP, LP | Other | Series D Preferred Stock | 5,133,076 | - footnote F1 | - | |
| ||||||
| Foresite Capital Management IV, LLC - 10% Owner | Other | Common Stock | 1,340,878 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Common Stock | 335,521 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Common Stock | 37,855 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Common Stock | 37,855 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Common Stock | 37,855 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Common Stock | 229,428 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Common Stock | 697,885 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Common Stock | 1,626 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Common Stock | 67,207 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Common Stock | 458,855 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Common Stock | 348,942 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Common Stock | 922 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Open-market purchase | Common Stock | 55,555 | $18.00 | $1.00M | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Common Stock | 38,133 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Common Stock | 408,725 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Series A Preferred Stock | 10,000,000 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Series A-1 Preferred Stock | 2,502,252 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Series A-1 Preferred Stock | 5,204,684 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Series A-1 Preferred Stock | 2,602,342 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Series B-1 Preferred Stock | 282,317 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Series B-1 Preferred Stock | 282,317 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Series B-1 Preferred Stock | 282,317 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Series B-1 Preferred Stock | 3,048,192 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Series C Preferred Stock | 12,123 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Series C Preferred Stock | 6,878 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Series C-1 Preferred Stock | 501,219 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Series C-1 Preferred Stock | 284,392 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Series D Preferred Stock | 1,711,025 | $0.00 | - | |
| Foresite Capital Management IV, LLC - 10% Owner | Other | Series D Preferred Stock | 3,422,051 | $0.00 | - | |
| Kenneth C. Frazier | Open-market purchase | Common Stock | 111,111 | $18.00 | $2.00M | |
| Josh Wolfe | Open-market purchase | Common Stock | 138,888 | $18.00 | $2.50M | |
| Josh Wolfe | Open-market purchase | Common Stock | 138,888 | $18.00 | $2.50M | |
| Josh Wolfe | Other | Common Stock | 2,387,705 | - footnote F3,F4 | - | |
| Josh Wolfe | Other | Common Stock | 1,151,540 | - footnote F4,F6,F7 | - | |
| Josh Wolfe | Other | Common Stock | 2,155,765 | - footnote F6,F7,F8,F9,F10 | - | |
| Josh Wolfe | Other | Series A Preferred Stock | 10,000,000 | - footnote F3 | - | |
| Josh Wolfe | Other | Series A-1 Preferred Stock | 7,807,026 | - footnote F4 | - | |
| Josh Wolfe | Other | Series A-1 Preferred Stock | 2,502,252 | - footnote F4 | - | |
| Josh Wolfe | Other | Series B Preferred Stock | 796,380 | - footnote F6 | - | |
| Josh Wolfe | Other | Series B Preferred Stock | 530,920 | - footnote F6 | - | |
| Josh Wolfe | Other | Series B-1 Preferred Stock | 5,289,322 | - footnote F7 | - | |
| Josh Wolfe | Other | Series B-1 Preferred Stock | 3,526,215 | - footnote F7 | - | |
| Josh Wolfe | Other | Series C Preferred Stock | 303,360 | - footnote F8 | - | |
| Josh Wolfe | Other | Series C-1 Preferred Stock | 1,450,614 | - footnote F9 | - | |
| Josh Wolfe | Other | Series D Preferred Stock | 10,266,152 | - footnote F10 | - | |
| ||||||
| Lux Venture Partners V, LLC | Open-market purchase | Common Stock | 138,888 | $18.00 | $2.50M | |
| Lux Venture Partners V, LLC | Open-market purchase | Common Stock | 138,888 | $18.00 | $2.50M | |
| Lux Venture Partners V, LLC | Other | Common Stock | 2,387,705 | - footnote F3,F4 | - | |
| Lux Venture Partners V, LLC | Other | Common Stock | 1,151,540 | - footnote F4,F6,F7 | - | |
| Lux Venture Partners V, LLC | Other | Common Stock | 2,155,765 | - footnote F6,F7,F8,F9,F10 | - | |
| Lux Venture Partners V, LLC | Other | Series A Preferred Stock | 10,000,000 | - footnote F3 | - | |
| Lux Venture Partners V, LLC | Other | Series A-1 Preferred Stock | 7,807,026 | - footnote F4 | - | |
| Lux Venture Partners V, LLC | Other | Series A-1 Preferred Stock | 2,502,252 | - footnote F4 | - | |
| Lux Venture Partners V, LLC | Other | Series B Preferred Stock | 796,380 | - footnote F6 | - | |
| Lux Venture Partners V, LLC | Other | Series B Preferred Stock | 530,920 | - footnote F6 | - | |
| Lux Venture Partners V, LLC | Other | Series B-1 Preferred Stock | 5,289,322 | - footnote F7 | - | |
| Lux Venture Partners V, LLC | Other | Series B-1 Preferred Stock | 3,526,215 | - footnote F7 | - | |
| Lux Venture Partners V, LLC | Other | Series C Preferred Stock | 303,360 | - footnote F8 | - | |
| Lux Venture Partners V, LLC | Other | Series C-1 Preferred Stock | 1,450,614 | - footnote F9 | - | |
| Lux Venture Partners V, LLC | Other | Series D Preferred Stock | 10,266,152 | - footnote F10 | - | |
| ||||||
Item 7.01, 8.01, 9.01
Item 7.01, 8.01, 9.01
Item 7.01, 9.01
Item 2.02, 9.01
EIKN insider trading FAQ
What is the latest insider trade for EIKN?
Eikon Therapeutics, Inc. (EIKN) had 1 insider filing in the last 90 days, with the most recent on 8 September 2026. The full record for EIKN runs to 14 Form 4 filings, the earliest from 6 February 2026. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying EIKN stock?
1 insider purchase of EIKN was filed in the last 90 days, totaling $1.03M.
How many insiders are selling EIKN stock?
No insider sales of EIKN were filed in the last 90 days.
Where can I see EIKN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects EIKN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Column Group IV GP, LP view on EDGAR
- - Michael A. Klobuchar view on EDGAR
- - Robert Luther Huffines view on EDGAR
- - Kenneth C. Frazier view on EDGAR
- - Roger M. Perlmutter view on EDGAR
- - Benjamin Bruno Thorner view on EDGAR
- - Roy D. Baynes view on EDGAR
- - Alfred Lloyd Bowie Jr. view on EDGAR
- - Roger M. Perlmutter view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where EIKN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow EIKN with a 7-day demo
- EIKN on your watchlist
- Every EIKN Form 4 filing on record
- Up to 3 months of EIKN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
